OLV RESEARCH UNIT
ActiveFor OLV RESEARCH UNIT, at least two filing cycles of the annual accounts are missing. The 2022 annual accounts show equity of €343k and a net result of €-81k. Equity is shrinking by ~14.9% per year across the filed fiscal years. Its solvency ranks better than 94% of 47 sector peers (fiscal year 2022). The company has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
No current score
Figures too old
The available figures for FY 2022 are too old to assess current financial health.
Filing: At least two filing cycles are missing
Axes, FY 2022 · tick = 2021
Profitability0=
Solvency100=
Growth32=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2022Solvency, return and age of the figures
Solvency
94.5%
Return on assets
-22.2%
Age of the figures
45 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Sector 21
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2023, 3 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 10 filingsPosition against the passed deadline
31-12-2023 close31-07-2024 deadline18-09-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-12-2022 was due by 31-07-2023 and was filed on 31-08-2023, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
not filed
2022
31 d late
2021
61 d late
2020
26 d late
2019
84 d late
← before the deadline
after the deadline →
Financials · fiscal year 2022, abbreviated schema
Equity
€343k▼ 19.0%
2021 · €424k
2018: €655k
2019: €572k
2020: €522k
2021: €424k
2018 → 2022
Total assets
€363k▼ 18.7%
2021 · €447k
2018: €656k
2019: €589k
2020: €559k
2021: €447k
2018 → 2022
Net result
€-81k▲ 17.7%
2021 · €-98k
2018: €-51k
2019: €-83k
2020: €-50k
2021: €-98k
2018 → 2022
Working capital
€93k▼ 41.9%
2021 · €160k
2018: €371k
2019: €303k
2020: €246k
2021: €160k
2018 → 2022
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20182019202020212022Trend
Equity€655k-€572k▼ 12.6%€522k▼ 8.8%€424k▼ 18.8%€343k▼ 19.0%
Operating result€-50k-€-83k▼ 66.4%€-50k▲ 39.3%€-96k▼ 92.5%€-81k▲ 16.5%
Net result€-51k-€-83k▼ 62.4%€-50k▲ 39.2%€-98k▼ 94.5%€-81k▲ 17.7%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €81k in 2022 against €96k in 2021; the loss shrinks.
Balance-sheet composition
2022 in colour, 2021 as the grey bar beneath
Assets €363k
Fixed assets
€250k▼ 5.2%
Current assets
€113k▼ 38.3%
Equity and liabilities €363k
Equity
€343k▼ 19.0%
Debt
€20k▼ 13.4%
The debt ratio rises from 5.2% to 5.5%. Equity and debt are lower.
Key figures and ratios
EBITDA
€-60k▲
2021 · €-77k
Cash flow
€-60k▲
2021 · €-78k
Solvency
94.5%▼
2021 · 94.8%
Current ratio
5.61▼
2021 · 7.88
Quick ratio
5.61▼
2021 · 7.88
Debt / equity
0.06▲
2021 · 0.05
ROE
-23.5%▼
2021 · -23.1%
ROA
-22.2%▼
2021 · -21.9%
Interest coverage
-426.67▼
2021 · -47.76
Debt
€20k▼
2021 · €23k
Debt ≤ 1 year
€20k▼
2021 · €23k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2022 against 2021
Balance sheet
Code20212022
Assets
Total assets20/58€447k€363k▼
Fixed assets21/28€264k€250k▼
Intangible fixed assets21€22k€18k▼
Tangible fixed assets22/27€242k€232k▼
Land and buildings22€240k€227k▼
Plant, machinery and equipment23-€2k
Furniture and vehicles24€1k€3k▲
Financial fixed assets28€50€50=
Current assets29/58€183k€113k▼
Amounts receivable within one year40/41€11k€14k▲
Trade receivables40€6k€6k▼
Other amounts receivable41€6k€8k▲
Current investments50/53€170k€90k▼
Cash at bank and in hand54/58€2k€9k▲
Equity and liabilities
Total equity and liabilities10/49€447k€363k▼
Equity10/15€424k€343k▼
Profit (loss) carried forward14€424k€343k▼
Amounts payable17/49€23k€20k▼
Amounts payable within one year42/48€23k€20k▼
Trade debts44€23k€20k▼
Suppliers440/4€23k€20k▼
Income statement
Code20212022
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€20k€21k▲
Other operating charges640/8€11k€3k▼
Gross operating margin9900€-66k€-57k▲
Operating profit (loss)9901€-96k€-81k▲
Financial charges65/66B€2k€141▼
Recurring financial charges65€2k€141▼
Profit (loss) for the period before taxes9903€-98k€-81k▲
Profit (loss) for the period9904€-98k€-81k▲
Profit (loss) for the period to be appropriated9905€-98k€-81k▲
Appropriation of the result
Profit (loss) to be appropriated9906€424k€343k▼
Profit (loss) brought forward from the previous period14P€522k€424k▼
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 31 days late
2022
30-09
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 61 days late
2021
31-12
Financial
Weakest financial yearnet €-98k
Net result drops to €-98k, the lowest in the series; recovery starts the following year.
26-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 26 days late
2020
23-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 84 days late
2019
14-10
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 75 days late
2018
04-12
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 126 days late
2017
27-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
13-07
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
2015
28-08
NBB filing
Annual accounts filed
fiscal year 2014 · abbreviated schema · 28 days late
2014
16-07
NBB filing
Annual accounts filed
fiscal year 2013 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Aalst
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Moorselbaan 1649300 AalstGround area
1,281 m²
Parcel 41303E0485/00N000, Flanders. Linked by address, not a title deed.
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 41303E0485/00N000 | Flanders | 1,280 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
bioprojet benelux
BE 0887.869.605
Sint-Jans-Molenbeek · Eq €346k
PROMACON
BE 0444.408.963
Hove · Eq €374k
MY HEALTH INTERNATIONAL
BE 0684.959.659
Lummen · Eq €376k
Sartorius Xpress Biologics
BE 0550.686.915
Herstal · Eq €280k
D2S Pharma
BE 0563.446.868
Oudenaarde · Eq €425k
Of 148 companies in sector 21100 we hold annual accounts for 108. 72 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formNon-profit association
Founded17-01-2001
Fiscal year end31-12
Activities, NACEBEL
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
85120
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.